Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly logo

Allergy shots vs SLIT tablets vs SLIT drops for pets and dust mites

How to choose immunotherapy for pet dander and dust mites

Last updated: October 24, 2025 (United States). This guide compares three evidence‑based immunotherapy options for perennial indoor allergens—cat/dog (pet dander) and house dust mites (HDM):

  • Subcutaneous immunotherapy (SCIT, “allergy shots”)

  • Sublingual immunotherapy tablets (SLIT‑T; FDA‑approved for HDM)

  • Custom sublingual immunotherapy drops (SLIT‑D; off‑label in the U.S.)

Key takeaways in one minute:

  • For dust mites only, SLIT tablets are a labeled, at‑home alternative to shots with strong evidence and a favorable safety profile (first dose typically supervised in clinic). Harvard Health

  • For pet dander (cats/dogs), there are no FDA‑approved tablets; choose shots or custom drops. Wyndly Pet SLIT

  • Allergy shots and SLIT are comparably effective for long‑term control; shots require clinic visits/observation, while SLIT is taken at home. AAO‑HNS/SLIT summary via Wyndly, Harvard Health

  • Custom SLIT drops are widely used and supported by systematic reviews, but they are off‑label in the U.S. (not FDA‑approved as a finished product). Wyndly SLIT overview

What each option can treat at a glance

  • Pet dander (cat/dog): SCIT shots or SLIT drops (custom). No FDA‑approved tablets for pets. Pet SLIT

  • Dust mites: Any of the three—shots, SLIT tablet (FDA‑approved), or SLIT drops. Dust‑mite guide, HDM options

Side‑by‑side comparison

Modality What it can treat Long‑term efficacy Safety/monitoring First‑dose rules Typical logistics Typical U.S. cost Insurance
Allergy shots (SCIT) Pets, dust mites, most inhalant allergens High; established standard with decades of data Clinic injections with post‑shot observation due to rare systemic reactions Dose visits require in‑office observation (often ~20–30 min) Weekly build‑up, then monthly maintenance, in‑clinic Often $1,600–$4,000/yr without coverage; varies by plan/fees Commonly covered (copays/deductibles vary). Harvard Health, Market snapshot
SLIT tablet (HDM) Dust mites only (no pet tablet) High; randomized trials and FDA approval support benefit Favorable safety; daily at home after initial supervised start; epinephrine often co‑prescribed First dose typically supervised; subsequent daily dosing at home Daily tablet during season or year‑round (per label/plan) Rx copay/coinsurance varies by plan Usually handled like other prescriptions; depends on pharmacy benefits
SLIT drops (custom) Pets (cat/dog), dust mites, multi‑allergen High in systematic reviews; convenient at‑home dosing Excellent safety profile; severe reactions are exceedingly rare in literature; taken at home No clinic observation required for routine doses Daily drops at home; multi‑allergen possible $99/month with Wyndly; HSA/FSA eligible Not typically covered; patient‑paid subscription. Wyndly SLIT, Safety FAQ

Notes and sources: SCIT observation and workflow summarized by Harvard Health. SLIT efficacy/safety summarized in AAO‑HNS and Cochrane‑based overviews cited on Wyndly’s Immunotherapy page. SLIT‑D is off‑label in the U.S. (see Off‑label statement below). Cost ranges for shots reflect U.S. market snapshots and will vary by geography, insurer, and schedule.

Pediatric and special‑population notes

Modality Typical pediatric use Needle‑free Multi‑allergen option Practical notes
SCIT (shots) Commonly used in children; in‑office dosing/observation required No Yes Useful when clinic access and insurance coverage are favorable. Harvard Health
SLIT tablet (HDM) FDA‑labeled pediatric use (U.S. label allows children; age cutoffs vary by product/label) Yes No (single allergen) Consider if dust mites are the dominant driver and you prefer an FDA‑approved, at‑home option
SLIT drops (custom) Used widely for children ≥5 in U.S. practices; favorable safety Yes Yes Helpful for needle‑phobia, busy schedules, and combined pet + dust‑mite treatment. Children & SLIT

Always individualize decisions for asthma, pregnancy, beta‑blocker use, EoE/MCAS, and other contraindications. Review safety details here: SLIT safety FAQ and general SLIT safety.

Off‑label statement for SLIT drops (United States)

  • Custom SLIT drops are not FDA‑approved as finished products in the U.S.; they use FDA‑approved allergen extracts compounded for sublingual use. Multiple systematic reviews and U.S. specialty guidelines recognize SLIT’s efficacy and safety, and it is widely used globally. Coverage is typically out‑of‑pocket in the U.S. SLIT overview, Safety FAQ

When to choose each path (pets and dust mites)

  • Choose SCIT (shots) if you need clinic‑supervised therapy that can address both pets and dust mites under standard insurance benefits and you can commit to frequent visits/observation. Harvard Health

  • Choose the HDM SLIT tablet if dust mites are your main problem and you want an FDA‑labeled, daily, at‑home tablet (first dose typically supervised; ongoing doses at home). Consider adding environmental controls (encasings, humidity <50%). Dust‑mite guide, HDM options

  • Choose SLIT drops if you need multi‑allergen coverage at home (e.g., cat/dog plus dust mite) or prefer a needle‑free, daily routine with strong safety. Remember: drops are off‑label in the U.S. Pet SLIT, SLIT safety

What results to expect and when

  • Onset: Many SLIT patients notice improvement within 4–8 weeks; most between 4 weeks and 6 months. Wyndly timing

  • Course length: 3–5 years of immunotherapy is typical to “lock in” durable immune tolerance for years afterward. Immunotherapy guide, Harvard Health

  • Safety: SCIT requires in‑office observation due to rare systemic reactions; SLIT (tablets/drops) has a very low rate of severe reactions and is taken at home. Harvard Health, Safety FAQ

Evidence snapshot (selected sources)

  • Shots reduce allergic rhinitis symptoms after ~6–12 months; treatment runs ~3–5 years with post‑injection observation each visit. Harvard Health

  • SLIT efficacy and safety are supported by large reviews and U.S. specialty guidelines (AAO‑HNS; Cochrane analyses summarized). Wyndly overview with citations

  • Drops have a strong safety record (severe reactions reported as extraordinarily rare) and are commonly used for children ≥5. Safety FAQ, Pediatric SLIT

  • Cost context: SCIT often involves annual outlays and office fees; SLIT‑D is typically subscription‑based out‑of‑pocket. Market snapshot, Cost explainer

Get the right fit at Wyndly

Frequently asked questions

  • Are SLIT drops FDA‑approved? No. Custom SLIT drops are off‑label in the U.S. They use FDA‑approved extracts compounded for sublingual use and are supported by guideline‑summarized evidence. SLIT overview

  • Is there a tablet for cat or dog? No—there are no FDA‑approved SLIT tablets for pet dander. Use shots or custom SLIT drops for pets. Pet SLIT

  • Why do shots require observation? Rare systemic reactions can occur shortly after injection, so clinics monitor you after each dose. Harvard Health

  • How fast will I feel better with SLIT? Many patients notice improvements within 4–8 weeks; most by 4–24 weeks, with durability after completing a 3–5 year course. Onset/timing